 | | |  | I recently wrote to you about a new lung cancer treatment that is showing great promise in its first clinical trials.
Guided by computerized imagery, stereotactic ablative radiotherapy (SABR) pinpoints small tumors with precise radiation and requires much shorter treatment time, resulting in fewer side effects.
Today, I’m writing once again to ask you to support the Annual Fund by making a gift to the 2016 Spring Appeal. | | | If you’ve already sent a contribution, please accept my genuine thanks and forgive this reminder. If not, I hope you’ll give now to help our researchers develop more therapies like this one, which result in better outcomes for patients.
Whatever the amount of your gift, please know that every dollar helps bring us closer to our goal to end cancer.
SABR is just one of scores of projects our dedicated researchers are working on to push the envelope to develop even more novel and potentially lifesaving therapies for cancer patients.
Your gift to the Spring Appeal can help make life better for our patients, their families and their loved ones. Please be as generous as you can.
Thank you again for joining MD Anderson in Making Cancer History®. |  | Ronald A. DePinho, M.D.
President
MD Anderson |
|  |
|
